|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 1/28/09 Novartis AG 20-F 12/31/08 9:6.4M Merrill Corp/New/FA |
Document/Exhibit Description Pages Size 1: 20-F Annual Report of a Foreign Private Issuer HTML 3.50M 2: EX-1.1 Underwriting Agreement HTML 125K 3: EX-1.2 Underwriting Agreement HTML 307K 4: EX-4.5 Instrument Defining the Rights of Security Holders HTML 488K 5: EX-4.6 Instrument Defining the Rights of Security Holders HTML 128K 6: EX-12.1 Statement re: Computation of Ratios HTML 14K 7: EX-12.2 Statement re: Computation of Ratios HTML 14K 8: EX-13.1 Annual or Quarterly Report to Security Holders HTML 11K 9: EX-14.1 Code of Ethics HTML 9K
Exhibit 13.1
CERTIFICATION OF DANIEL VASELLA,
CHAIRMAN AND CHIEF EXECUTIVE OFFICER OF
NOVARTIS AG AND RAYMUND BREU, CHIEF FINANCIAL OFFICER OF NOVARTIS AG,
PURSUANT TO SECTION 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Novartis AG (the “Company”) on Form 20-F for the period ending December 31, 2006, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certify that to the best of our knowledge:
1. The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
|
/s/ DANIEL VASELLA |
|
|
Name: |
Daniel Vasella |
|
|
Title: |
Chairman and Chief Executive Officer |
|
|
|
|
|
|
|
/s/ RAYMUND BREU |
|
|
Name: |
Raymund Breu |
|
|
Title: |
Chief Financial Officer |
Date: January 28, 2009
| This ‘20-F’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 1/28/09 | 6-K | ||
| For Period End: | 12/31/08 | |||
| 12/31/06 | 20-F | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/16/09 SEC UPLOAD¶ 9/30/17 1:21K Novartis AG 6/22/09 SEC UPLOAD¶ 9/30/17 1:48K Novartis AG |